Loading…

Downregulation of miR-200a protects cardiomyocyte against apoptosis

[Display omitted] •MiR-200a is upregulated and responsible for the apoptosis in AMI models.•The inhibition of miR-200a protects cardiomyocytes against apoptosis.•MiR-200a derived signaling pathway is potential therapeutic target for AMI. Acute myocardial infarction (AMI) is a major clinical manifest...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2020-03, Vol.123, p.109303-109303, Article 109303
Main Authors: Wang, Yansong, Jiang, Yanan, Sun, Xi, Shen, Xiuyun, Wang, Hui, Dong, Chaorun, Lu, Baojiang, Yan, Yan, Lu, Yuan, Fasae, Moyondafoluwa Blessing, Liu, Bing, Bai, Yunlong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723
cites cdi_FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723
container_end_page 109303
container_issue
container_start_page 109303
container_title Biomedicine & pharmacotherapy
container_volume 123
creator Wang, Yansong
Jiang, Yanan
Sun, Xi
Shen, Xiuyun
Wang, Hui
Dong, Chaorun
Lu, Baojiang
Yan, Yan
Lu, Yuan
Fasae, Moyondafoluwa Blessing
Liu, Bing
Bai, Yunlong
description [Display omitted] •MiR-200a is upregulated and responsible for the apoptosis in AMI models.•The inhibition of miR-200a protects cardiomyocytes against apoptosis.•MiR-200a derived signaling pathway is potential therapeutic target for AMI. Acute myocardial infarction (AMI) is a major clinical manifestation of ischemic heart disease and represents a significant cause of morbidity and mortality. However, key regulators in the pathogenesis of ischemic heart disease remain controversial. The present study was designed to investigate the involvement of miR-200a and its related mechanism in AMI. Left coronary artery (LCA) ligation was conducted to induce an AMI mouse model. The infarct size was measured by TTC staining. H2O2 was used to induce an AMI model in vitro. miR-200a mimics, anti-miR-200a antisense oligodeoxyribonucleotides (AMO-200a), as well as corresponding negative controls were transfected into cardiomyocytes to observe the effect of miR-200a. Flow cytometry was used to detect cell apoptosis. Real-time PCR, immunofluorescence and western blot assays were used to evaluate gene expression at RNA or protein levels, respectively. Apoptosis was activated in AMI models. The expression of miR-200a was upregulated both in the peri-infarcted region of mice myocardium and H2O2-treated cardiomyocytes. The co-administration of AMO-200a decreased the number of apoptosis cells and altered the expression of apoptosis related proteins. Interestingly, bioinformatics analysis results revealed that miR-200a could bind to the 3′-untranslated regions (3’-UTR) of Fus mRNA. In addition, the expression of Fus was downregulated in the AMI mouse models and in H2O2-treated cardiomyocytes. The alteration of miR-200a negatively regulated Fus expression in cardiomyocytes. Also, the protective effect of AMO-200a was observed through its regulation of Fus. MiR-200a-dependent apoptosis signaling pathway plays an important role in the pathogenesis of AMI injury and could be an exciting potential therapeutic target.
doi_str_mv 10.1016/j.biopha.2019.109303
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2333606665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332219308716</els_id><sourcerecordid>2333606665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMouq5-A5EevXSdJE2aXgRZ_8KCIHoOaTpds2ybmnSV_fZ26erR08Dw3rx5P0IuKMwoUHm9mpXOdx9mxoAWw6rgwA_IhBYCUgmQH5IJ5IKnnDN2Qk5jXAGAkFwdkxNOVSFBqgmZ3_nvNuBysza9823i66RxrykDMEkXfI-2j4k1oXK-2Xq77TExS-Pa2Cem813vo4tn5Kg264jn-zkl7w_3b_OndPHy-Dy_XaQ2A9WnTNkqZ3ktM2EMLxgrWQWCq1xSCUqKIjMFlJIXJdZUsBylRC4tKqFMpXLGp-RqvDs89rnB2OvGRYvrtWnRb6JmnPOhlZRikGaj1AYfY8Bad8E1Jmw1Bb3Dp1d6xKd3-PSIb7Bd7hM2ZYPVn-mX1yC4GQU49PxyGHS0DluLlQsDKl1593_CD4kogS0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2333606665</pqid></control><display><type>article</type><title>Downregulation of miR-200a protects cardiomyocyte against apoptosis</title><source>ScienceDirect Freedom Collection</source><creator>Wang, Yansong ; Jiang, Yanan ; Sun, Xi ; Shen, Xiuyun ; Wang, Hui ; Dong, Chaorun ; Lu, Baojiang ; Yan, Yan ; Lu, Yuan ; Fasae, Moyondafoluwa Blessing ; Liu, Bing ; Bai, Yunlong</creator><creatorcontrib>Wang, Yansong ; Jiang, Yanan ; Sun, Xi ; Shen, Xiuyun ; Wang, Hui ; Dong, Chaorun ; Lu, Baojiang ; Yan, Yan ; Lu, Yuan ; Fasae, Moyondafoluwa Blessing ; Liu, Bing ; Bai, Yunlong</creatorcontrib><description>[Display omitted] •MiR-200a is upregulated and responsible for the apoptosis in AMI models.•The inhibition of miR-200a protects cardiomyocytes against apoptosis.•MiR-200a derived signaling pathway is potential therapeutic target for AMI. Acute myocardial infarction (AMI) is a major clinical manifestation of ischemic heart disease and represents a significant cause of morbidity and mortality. However, key regulators in the pathogenesis of ischemic heart disease remain controversial. The present study was designed to investigate the involvement of miR-200a and its related mechanism in AMI. Left coronary artery (LCA) ligation was conducted to induce an AMI mouse model. The infarct size was measured by TTC staining. H2O2 was used to induce an AMI model in vitro. miR-200a mimics, anti-miR-200a antisense oligodeoxyribonucleotides (AMO-200a), as well as corresponding negative controls were transfected into cardiomyocytes to observe the effect of miR-200a. Flow cytometry was used to detect cell apoptosis. Real-time PCR, immunofluorescence and western blot assays were used to evaluate gene expression at RNA or protein levels, respectively. Apoptosis was activated in AMI models. The expression of miR-200a was upregulated both in the peri-infarcted region of mice myocardium and H2O2-treated cardiomyocytes. The co-administration of AMO-200a decreased the number of apoptosis cells and altered the expression of apoptosis related proteins. Interestingly, bioinformatics analysis results revealed that miR-200a could bind to the 3′-untranslated regions (3’-UTR) of Fus mRNA. In addition, the expression of Fus was downregulated in the AMI mouse models and in H2O2-treated cardiomyocytes. The alteration of miR-200a negatively regulated Fus expression in cardiomyocytes. Also, the protective effect of AMO-200a was observed through its regulation of Fus. MiR-200a-dependent apoptosis signaling pathway plays an important role in the pathogenesis of AMI injury and could be an exciting potential therapeutic target.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2019.109303</identifier><identifier>PMID: 31896068</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Apoptosis ; Fused in sarcoma ; miR-200a ; Myocardial ischemia</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2020-03, Vol.123, p.109303-109303, Article 109303</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Masson SAS.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723</citedby><cites>FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31896068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yansong</creatorcontrib><creatorcontrib>Jiang, Yanan</creatorcontrib><creatorcontrib>Sun, Xi</creatorcontrib><creatorcontrib>Shen, Xiuyun</creatorcontrib><creatorcontrib>Wang, Hui</creatorcontrib><creatorcontrib>Dong, Chaorun</creatorcontrib><creatorcontrib>Lu, Baojiang</creatorcontrib><creatorcontrib>Yan, Yan</creatorcontrib><creatorcontrib>Lu, Yuan</creatorcontrib><creatorcontrib>Fasae, Moyondafoluwa Blessing</creatorcontrib><creatorcontrib>Liu, Bing</creatorcontrib><creatorcontrib>Bai, Yunlong</creatorcontrib><title>Downregulation of miR-200a protects cardiomyocyte against apoptosis</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>[Display omitted] •MiR-200a is upregulated and responsible for the apoptosis in AMI models.•The inhibition of miR-200a protects cardiomyocytes against apoptosis.•MiR-200a derived signaling pathway is potential therapeutic target for AMI. Acute myocardial infarction (AMI) is a major clinical manifestation of ischemic heart disease and represents a significant cause of morbidity and mortality. However, key regulators in the pathogenesis of ischemic heart disease remain controversial. The present study was designed to investigate the involvement of miR-200a and its related mechanism in AMI. Left coronary artery (LCA) ligation was conducted to induce an AMI mouse model. The infarct size was measured by TTC staining. H2O2 was used to induce an AMI model in vitro. miR-200a mimics, anti-miR-200a antisense oligodeoxyribonucleotides (AMO-200a), as well as corresponding negative controls were transfected into cardiomyocytes to observe the effect of miR-200a. Flow cytometry was used to detect cell apoptosis. Real-time PCR, immunofluorescence and western blot assays were used to evaluate gene expression at RNA or protein levels, respectively. Apoptosis was activated in AMI models. The expression of miR-200a was upregulated both in the peri-infarcted region of mice myocardium and H2O2-treated cardiomyocytes. The co-administration of AMO-200a decreased the number of apoptosis cells and altered the expression of apoptosis related proteins. Interestingly, bioinformatics analysis results revealed that miR-200a could bind to the 3′-untranslated regions (3’-UTR) of Fus mRNA. In addition, the expression of Fus was downregulated in the AMI mouse models and in H2O2-treated cardiomyocytes. The alteration of miR-200a negatively regulated Fus expression in cardiomyocytes. Also, the protective effect of AMO-200a was observed through its regulation of Fus. MiR-200a-dependent apoptosis signaling pathway plays an important role in the pathogenesis of AMI injury and could be an exciting potential therapeutic target.</description><subject>Apoptosis</subject><subject>Fused in sarcoma</subject><subject>miR-200a</subject><subject>Myocardial ischemia</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LxDAQxYMouq5-A5EevXSdJE2aXgRZ_8KCIHoOaTpds2ybmnSV_fZ26erR08Dw3rx5P0IuKMwoUHm9mpXOdx9mxoAWw6rgwA_IhBYCUgmQH5IJ5IKnnDN2Qk5jXAGAkFwdkxNOVSFBqgmZ3_nvNuBysza9823i66RxrykDMEkXfI-2j4k1oXK-2Xq77TExS-Pa2Cem813vo4tn5Kg264jn-zkl7w_3b_OndPHy-Dy_XaQ2A9WnTNkqZ3ktM2EMLxgrWQWCq1xSCUqKIjMFlJIXJdZUsBylRC4tKqFMpXLGp-RqvDs89rnB2OvGRYvrtWnRb6JmnPOhlZRikGaj1AYfY8Bad8E1Jmw1Bb3Dp1d6xKd3-PSIb7Bd7hM2ZYPVn-mX1yC4GQU49PxyGHS0DluLlQsDKl1593_CD4kogS0</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Wang, Yansong</creator><creator>Jiang, Yanan</creator><creator>Sun, Xi</creator><creator>Shen, Xiuyun</creator><creator>Wang, Hui</creator><creator>Dong, Chaorun</creator><creator>Lu, Baojiang</creator><creator>Yan, Yan</creator><creator>Lu, Yuan</creator><creator>Fasae, Moyondafoluwa Blessing</creator><creator>Liu, Bing</creator><creator>Bai, Yunlong</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202003</creationdate><title>Downregulation of miR-200a protects cardiomyocyte against apoptosis</title><author>Wang, Yansong ; Jiang, Yanan ; Sun, Xi ; Shen, Xiuyun ; Wang, Hui ; Dong, Chaorun ; Lu, Baojiang ; Yan, Yan ; Lu, Yuan ; Fasae, Moyondafoluwa Blessing ; Liu, Bing ; Bai, Yunlong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Fused in sarcoma</topic><topic>miR-200a</topic><topic>Myocardial ischemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yansong</creatorcontrib><creatorcontrib>Jiang, Yanan</creatorcontrib><creatorcontrib>Sun, Xi</creatorcontrib><creatorcontrib>Shen, Xiuyun</creatorcontrib><creatorcontrib>Wang, Hui</creatorcontrib><creatorcontrib>Dong, Chaorun</creatorcontrib><creatorcontrib>Lu, Baojiang</creatorcontrib><creatorcontrib>Yan, Yan</creatorcontrib><creatorcontrib>Lu, Yuan</creatorcontrib><creatorcontrib>Fasae, Moyondafoluwa Blessing</creatorcontrib><creatorcontrib>Liu, Bing</creatorcontrib><creatorcontrib>Bai, Yunlong</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yansong</au><au>Jiang, Yanan</au><au>Sun, Xi</au><au>Shen, Xiuyun</au><au>Wang, Hui</au><au>Dong, Chaorun</au><au>Lu, Baojiang</au><au>Yan, Yan</au><au>Lu, Yuan</au><au>Fasae, Moyondafoluwa Blessing</au><au>Liu, Bing</au><au>Bai, Yunlong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Downregulation of miR-200a protects cardiomyocyte against apoptosis</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2020-03</date><risdate>2020</risdate><volume>123</volume><spage>109303</spage><epage>109303</epage><pages>109303-109303</pages><artnum>109303</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>[Display omitted] •MiR-200a is upregulated and responsible for the apoptosis in AMI models.•The inhibition of miR-200a protects cardiomyocytes against apoptosis.•MiR-200a derived signaling pathway is potential therapeutic target for AMI. Acute myocardial infarction (AMI) is a major clinical manifestation of ischemic heart disease and represents a significant cause of morbidity and mortality. However, key regulators in the pathogenesis of ischemic heart disease remain controversial. The present study was designed to investigate the involvement of miR-200a and its related mechanism in AMI. Left coronary artery (LCA) ligation was conducted to induce an AMI mouse model. The infarct size was measured by TTC staining. H2O2 was used to induce an AMI model in vitro. miR-200a mimics, anti-miR-200a antisense oligodeoxyribonucleotides (AMO-200a), as well as corresponding negative controls were transfected into cardiomyocytes to observe the effect of miR-200a. Flow cytometry was used to detect cell apoptosis. Real-time PCR, immunofluorescence and western blot assays were used to evaluate gene expression at RNA or protein levels, respectively. Apoptosis was activated in AMI models. The expression of miR-200a was upregulated both in the peri-infarcted region of mice myocardium and H2O2-treated cardiomyocytes. The co-administration of AMO-200a decreased the number of apoptosis cells and altered the expression of apoptosis related proteins. Interestingly, bioinformatics analysis results revealed that miR-200a could bind to the 3′-untranslated regions (3’-UTR) of Fus mRNA. In addition, the expression of Fus was downregulated in the AMI mouse models and in H2O2-treated cardiomyocytes. The alteration of miR-200a negatively regulated Fus expression in cardiomyocytes. Also, the protective effect of AMO-200a was observed through its regulation of Fus. MiR-200a-dependent apoptosis signaling pathway plays an important role in the pathogenesis of AMI injury and could be an exciting potential therapeutic target.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>31896068</pmid><doi>10.1016/j.biopha.2019.109303</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2020-03, Vol.123, p.109303-109303, Article 109303
issn 0753-3322
1950-6007
language eng
recordid cdi_proquest_miscellaneous_2333606665
source ScienceDirect Freedom Collection
subjects Apoptosis
Fused in sarcoma
miR-200a
Myocardial ischemia
title Downregulation of miR-200a protects cardiomyocyte against apoptosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A54%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Downregulation%20of%20miR-200a%20protects%20cardiomyocyte%20against%20apoptosis&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Wang,%20Yansong&rft.date=2020-03&rft.volume=123&rft.spage=109303&rft.epage=109303&rft.pages=109303-109303&rft.artnum=109303&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2019.109303&rft_dat=%3Cproquest_cross%3E2333606665%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-28cd727f645aa3922b2d05387616086594a90b639bef1527e66e36ce858ad8723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2333606665&rft_id=info:pmid/31896068&rfr_iscdi=true